| Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients NMA Okba, MA Müller, W Li, C Wang, CH GeurtsvanKessel, VM Corman, ... Emerging infectious diseases 26 (7), 1478, 2020 | 1615 | 2020 |
| Clinical and virological data of the first cases of COVID-19 in Europe: a case series FX Lescure, L Bouadma, D Nguyen, M Parisey, PH Wicky, S Behillil, ... The Lancet Infectious Diseases 20 (6), 697-706, 2020 | 1330 | 2020 |
| Evidence of sexual transmission of Zika virus E D’Ortenzio, S Matheron, X de Lamballerie, B Hubert, G Piorkowski, ... New England Journal of Medicine 374 (22), 2195-2198, 2016 | 814 | 2016 |
| Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy D Descamps, P Flandre, V Calvez, G Peytavin, V Meiffredy, G Collin, ... Jama 283 (2), 205-211, 2000 | 504 | 2000 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 426 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 321 | 2021 |
| Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine-or efavirenz-based antiretroviral therapy JJ Parienti, V Massari, D Descamps, A Vabret, E Bouvet, B Larouzé, ... Clinical Infectious Diseases 38 (9), 1311-1316, 2004 | 319 | 2004 |
| Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial JL Meynard, M Vray, L Morand-Joubert, E Race, D Descamps, G Peytavin, ... Aids 16 (5), 727-736, 2002 | 305 | 2002 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 282 | 2015 |
| High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results … Y Yazdanpanah, C Fagard, D Descamps, AM Taburet, C Colin, ... Clinical Infectious Diseases 49 (9), 1441-1449, 2009 | 259 | 2009 |
| A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations L Grzelak, S Temmam, C Planchais, C Demeret, L Tondeur, C Huon, ... Science translational medicine 12 (559), eabc3103, 2020 | 254 | 2020 |
| Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses D Descamps, G Collin, F Letourneur, C Apetrei, F Damond, ... Journal of virology 71 (11), 8893-8898, 1997 | 247 | 1997 |
| Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome V Descamps, F Bouscarat, S Laglenne, E Aslangul, B Veber, D Descamps, ... British Journal of Dermatology 137 (4), 605-608, 1997 | 243 | 1997 |
| SARS-CoV-2 specific antibody responses in COVID-19 patients NMA Okba, MA Müller, W Li, C Wang, CH GeurtsvanKessel, VM Corman, ... MedRxiv, 2020.03. 18.20038059, 2020 | 235 | 2020 |
| Zika virus in the female genital tract N Prisant, L Bujan, H Benichou, PH Hayot, L Pavili, S Lurel, C Herrmann, ... The Lancet infectious diseases 16 (9), 1000-1001, 2016 | 231 | 2016 |
| Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C A Desnoyer, D Pospai, MP Lê, A Gervais, A Heurgué-Berlot, A Laradi, ... Journal of hepatology 65 (1), 40-47, 2016 | 205 | 2016 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 189 | 2016 |
| Hiv-2 molecular epidemiology B Visseaux, F Damond, S Matheron, D Descamps, C Charpentier Infection, Genetics and Evolution 46, 233-240, 2016 | 182 | 2016 |
| The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients E Teyssou, H Delagrèverie, B Visseaux, S Lambert-Niclot, S Brichler, ... The Journal of infection 83 (4), e1, 2021 | 172 | 2021 |
| HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF … P Frange, A Faye, V Avettand-Fenoël, E Bellaton, D Descamps, M Angin, ... The lancet HIV 3 (1), e49-e54, 2016 | 172 | 2016 |
